Continuous Improvement in Tablet Coating and Dry Granulation - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Continuous Improvement in Tablet Coating and Dry Granulation
Recent advances in equipment design and operation in spraying, drying, and mixing can improve the tablet-coating process.

Pharmaceutical Technology
pp. s12-s16


This study proves the functionality of the new roller compactors. It was possible to precisely produce a representative placebo granule formulation with negligible material waste during process start-up. Furthermore, the study shows that a suitable sieve setup offers the possibility to achieve a desired granule size by altering screen size and sieve speed.


1. R. Mueller and P. Kleinebudde, Eur. J. Pharm. Biopharm. 64 (3), 388-92 (2006).

2. R. Mueller et al., Drug. Dev. Ind. Pharm. 36 (2), 234-243 (2010).

3. R. Mueller and P. Kleinebudde, AAPS PharmSciTech. 28 (1), E21-31 (2007).

4. R.W. Miller, Pharm. Technol. 18 (3), 154-162 (1994).

5. P. Kleinebudde, Eur. J. Pharm. Biopharm. 58 (2), 317-326 (2004).

6. Y. Teng, Z. Qiu, and H. Wen, Eur. J. Pharm. Biopharm. 73 (2), 219-229 (2009).

Martin Hack* is vice-president and general manager, and Dejan Djuric, PhD, is manager of scientific operations, both at L.B. Bohle, 700 Veterans Circle, Suite 100, Warminster, PA 18974, tel. 215.957.1240,

* To whom all correspondence should be addressed.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here